Activation of the JNK-c-Jun pathway in response to irradiation facilitates Fas ligand secretion in h

来源 :第十届全国肝脏疾病临床学术大会 | 被引量 : 0次 | 上传用户:emma880222
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background It is well established that some irradiated liver non-parenchymal cells secrete proinflammatory cytokines to facilitate the development of radiation-induced liver disease.However, little is known on whether the irradiated hepatoma cells-mediated non-irradiated hepatocyte injury occurs in HCC patients.Here, we elucidated the roles of the irradiated hepatoma cells in driving non-irradiated hepatocyte injury and its underlying mechanism.Methods SMMC7721 HCC cells were cultured and divided into irradiated (4-Gy X-ray, R) and nonirradiated (NR) groups.At 24th hour after irradiation, conditioned medium (CM) from these cultures was mixed with normal culture medium in specific proportions, and termed as 7721-R-CM and 7721-NR-CM.Following incubation with these CM compound, the biological characteristics of L02 cells related to liver cell injury including proliferation,apoptosis, and liver dysfunction indices were comparatively analyzed.Simultaneously, the levels of proliferation-and apoptosis-related cytokines in irradiated and non-irradiated SMMC7721 cells were also measured.FasL as a cytokine with significantly differential expression, was selected to clarify its effects on L02 apoptosis.Subsequently, FasL expression following irradiation was examined in SMMC7721 and other HCC cells with varying malignant potentials,as well as in HCC tissues, the related mechanism of higher expression of FasL in irradiated HCC cells was further investigated.Results Apoptosis and liver dysfunction indices were all significantly enhanced in L02 cells treated with 7721-R-CM, whereas proliferation was suppressed, compared to those with 7721-NR-CM stimulation.FasL was identified as a leading differential cytokine in the irradiated SMMC7721 cells.Higher proportion of apoptosis was also found in L02 cells following FasL incubation.A recombinant Fas-Fc protein, which blocks Fas-FasL interaction, ameliorated 7721-R-CM-or FasL-induced apoptosis in L02 cells.FasL was highly expressed in a dosedependent manner, and peaked at the 24th hour post-irradiation, in different HCC cells and their culture supernatant.Meanwhile, phosphorylation levels of JNK, ERK, Akt, and p38 were all upregulated significantly in irradiated HCC cells.But, only JNK inhibition was validated to block radiation-induced FasL expression in HCC cells.c-Jun, the target transcription factor of JNK, was also activated.Conclusion In HCC cells, the JNK-c-Jun pathway plays an important role in mediating irradiation-induced FasL expression, which may be critical in determining non-irradiated hepatocyte injury.
其他文献
目的:回顾性研究聚乙二醇干扰素联合利巴韦林治疗慢丙肝合并2型糖尿病患者疗效和安全性.方法:入组G1、G2组,G1:慢丙肝合并2型糖尿病,空腹GLU值控制在(7.61±2.99)mmol/L,ALbl值控制在7.1%±2.0%,并且稳定4周以上,开始给予抗HCV治疗,治疗期间适时改变胰岛素用量或改变口服降糖药物种类及剂量控制血糖.G2:慢丙肝,给予抗HCV治疗.抗HCV治疗方案-聚乙二醇干扰素联合利
目的:观察解毒化瘀补虚法联合西药治疗乙型肝炎慢加急性肝衰竭(ACLF)临床疗效,并探讨其作用机理.方法:将60例慢性乙型肝炎ACLF患者随机分为中西医结合组30例与西医治疗组30例.西医治疗组给予西医内科综合治疗,中西医结合组在西医治疗的基础上分期加用解毒化瘀退黄方和肝脾调补退黄方,共治疗8周,随访到48周.比较两组治疗后第8、48周时的临床疗效,观察两组患者治疗第0、2、4、6、8、12、24、
随着肝硬化病程的进展,门脉高压和肝功能减退等症状不断加重,导致病人生活质量明显下降,尤以门脉高压症所致各类并发症使患者预后不良、病死率增加.但当前临床上使用的治疗药物并不能达到十分理想的疗效,尤其对于肝硬化晚期病人药物干预疗效更差.近年随着肝硬化门脉高压治疗研究的增多,对肝硬化门脉高压的干预手段也不断丰富,为门脉高压患者带来了希望.而非手术治疗是临床上应用最多的干预措施,下面本文将从药物治疗、介入
目的:通过肝脏瞬时弹性扫描技术和肝纤维化4项血清学指标,综合分析评价慢性肝病患者肝纤维化程度,为肝纤维化准确诊断及判断肝纤维化的进程提供更加可靠的依据.方法:对同一肝病患者同时做两项检查,一是通过化学发光法对患者血清肝纤维化4项(透明质酸HA,层黏蛋白LN,Ⅲ型前胶原PCⅢ,Ⅳ型胶原CⅣ)进行定量测定;二是通过瞬时弹性成像技术测量肝硬度值(liver stiffness measurement,L
目的:探讨ARID2对人肝癌细胞系凋亡的影响,明确ARID2是否是通过线粒体信号通路诱导肿瘤细胞的发生凋亡.方法:人肝癌细胞系HepG2、SK-Hep1分别被转染ARID2质粒96h后,并给予AnnexinV-FITC/7-AAD,JC-1染料染色30min后.流式细胞术分别被用于检测肝癌细胞的凋亡率以及肝癌细胞的线粒体膜势能的变化.荧光显微镜被用于观察染色后肝癌细胞形态学的变化.采用caspas
乙肝病毒(Hepatitis B Virus,HBV)是一种呈世界性分布、危害严重的传染病,每年导致超过60万人死于原发性肝癌和肝硬化.而肝细胞性肝癌是全世界最常见的恶性肿瘤之一,预后极差,同时肝癌早期诊断率低和影响预后因素广泛而有效干预手段少.MiRNA作为广泛生物学作用的内源性RNA,其在循环血中的稳定存在,已被证实与癌症包括肝癌的发生发展具有密切的生物学相关性,使之具备了成为肝癌诊断和预后生
目的:SALL4作为一种新的肝癌干细胞标志物逐渐被研究,有报道称其表达和预后相关,但其阳性率存在东、西方差异,作为肝癌预后标志物的价值有待被进一步证实,本研究目的是明确SALL4在肝癌中的表达情况及其临床病理特征,确证SALL4表达与肝癌进展及预后的相关性及其作为独立肝癌预后预测因素的可能性.方法:收集本院2015年1月-2015年12月收治的34例肝癌患者的肝切除或肝移植术后标本,选取相关的人口
目的:探讨HBV携带者危害及临床防治的价值.方法:从一个五万人居住区的45人肝硬化、肝癌患者进行回顾性调查,其中慢性乙型肝炎(CHB)12例,占26%,HBV携带者33人,占73%.在这45人中已死亡29人,占64%,死亡人数中CHB7例,占24%,HBV携带者22例,占76%.2008年8月-2015年11月对76例成人HBV携带者用乙肝免疫球蛋白(HB1G)乙肝疫苗(CHO)双嘧达莫联合治疗.
目的:探讨慢性乙型肝炎(CHB)及肝硬化患者血清纤维化指标透明质酸(HA)、层黏连蛋白(LN)、Ⅳ型胶原(Ⅳc)、人Ⅲ型前胶原(PCⅢ)含量及丙氨酸氨基转移酶(ALT)水平与病情严重程度的关系.方法:以30例正常体检人员为对照,检测129例CHB及肝硬化患者血清HA、LN、Ⅳc、PCⅢ的含量及ALT水平,同时结合临床特点,运用统计学方法对上述血清学指标的诊断价值进行分析.结果:CHB患者血清HA、
Objective To evaluate the survival benefit of non-bioartificial liver support system(NBALs) in the treatment of acute or chronic liver failure(ACLF) via a meta-analysis of randomized controlled trials
会议